Advertisement
Screener

GT BIOPHARMA, INC. (GTBP) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

GT BIOPHARMA, INC. Preferred Stock, Shares Authorized

GT BIOPHARMA, INC. (GTBP) had Preferred Stock, Shares Authorized of 15.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-14

  • 2026-06-30: Preferred Stock, Shares Authorized 15.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 15.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 15.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 15.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-3015.00M shares
10-Q · filed 2026-08-14
2026-03-3115.00M shares
10-Q · filed 2026-05-15
2025-12-3115.00M shares
10-Q · filed 2026-08-14
2025-09-3015.00M shares
10-Q/A · filed 2026-03-06
2025-06-3015.00M shares
10-Q/A · filed 2026-03-06
2025-03-3115.00M shares
10-Q · filed 2025-05-15
2024-12-3115.00M shares
10-Q/A · filed 2026-03-06
2024-09-3015.00M shares
10-Q · filed 2024-11-14
2024-06-3015.00M shares
10-Q · filed 2024-08-14
2024-03-3115.00M shares
10-Q · filed 2024-05-15
2023-12-3115.00M shares
10-K · filed 2025-02-21
2023-09-3015.00M shares
10-Q · filed 2023-11-01
2023-06-3015.00M shares
10-Q · filed 2023-08-07
2023-03-3115.00M shares
10-Q · filed 2023-05-15
2022-12-3115.00M shares
10-K · filed 2024-03-26
2022-09-3015.00M shares
10-Q · filed 2022-10-31
2022-06-3015.00M shares
10-Q · filed 2022-08-15
2022-03-3115.00M shares
10-Q · filed 2022-05-16
2021-12-3115.00M shares
10-K · filed 2023-03-30
2021-09-3015.00M shares
10-Q · filed 2021-11-10
2021-06-3015.00M shares
10-Q/A · filed 2021-12-29
2021-03-3115.00M shares
10-Q · filed 2021-05-17
2020-12-3115.00M shares
10-K · filed 2022-03-28
2020-09-3015.00M shares
10-Q · filed 2020-11-13
2020-06-3015.00M shares
10-Q/A · filed 2020-08-18
2020-03-3115.00M shares
10-Q · filed 2020-05-15
2019-12-3115.00M shares
10-K · filed 2021-04-16
2019-09-3015.00M shares
10-Q · filed 2019-11-14
2019-06-3015.00M shares
10-Q · filed 2019-08-14
2019-03-3115.00M shares
10-Q · filed 2019-05-15
2018-12-3115.00M shares
10-K · filed 2020-03-27
2018-09-3015.00M shares
10-Q · filed 2018-11-14
2018-06-3015.00M shares
10-Q · filed 2018-08-14
2018-03-3115.00M shares
10-Q · filed 2018-05-15
2017-12-3115.00M shares
10-K · filed 2019-03-29
2017-09-3015.00M shares
10-Q · filed 2017-11-14
2017-06-3015.00M shares
10-Q · filed 2017-08-11
2017-03-3115.00M shares
10-Q · filed 2017-04-28
2016-12-3115.00M shares
10-K · filed 2018-03-01
2016-09-3015.00M shares
10-Q/A · filed 2018-02-28
2016-06-3015.00M shares
10-Q/A · filed 2018-02-28
2016-03-3115.00M shares
10-Q/A · filed 2018-02-28
2015-12-3115.00M shares
10-K/A · filed 2018-02-28
2015-09-3015.00M shares
10-Q · filed 2015-11-13
2015-06-3015.00M shares
10-Q · filed 2015-08-14
2015-03-3115.00M shares
10-Q · filed 2015-05-14
2014-12-3115.00M shares
10-K/A · filed 2018-02-28
2014-09-3015.00M shares
10-Q · filed 2015-01-08
2014-06-3015.00M shares
10-Q · filed 2015-01-08
2014-03-3115.00M shares
10-Q · filed 2015-01-08
2013-12-3115.00M shares
10-K · filed 2015-03-31
2013-09-3015.00M shares
10-Q · filed 2014-12-17
2013-06-3015.00M shares
10-Q · filed 2014-12-12
2013-03-3115.00M shares
10-Q · filed 2014-12-10
2012-12-3115.00M shares
10-K · filed 2015-01-08
2012-09-3015.00M shares
10-Q · filed 2012-11-21
2012-06-3015.00M shares
10-Q/A · filed 2012-09-13
2012-03-3115.00M shares
10-Q · filed 2012-05-21
2011-12-3115.00M shares
10-K · filed 2014-11-18
2011-09-3015.00M shares
10-Q · filed 2011-11-21
2011-06-3015.00M shares
10-Q/A · filed 2011-09-12
2010-12-3115.00M shares
10-K · filed 2012-04-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88